Inhibition of the Differentiation of Dendritic Cells From CD34+ Progenitors by Tumor Cells: Role of Interleukin-6 and Macrophage Colony-Stimulating Factor

The Dendritic Cell System and its Role in Immunogenicity

Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,659 · see citing works

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977 · see citing works

Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., & Levy, R. (1996) · Nature Medicine · doi:10.1038/nm0196-52 · Cited by 1,804 · see citing works

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

Caux, C., Dezutter‐Dambuyant, C., Schmitt, D., & Banchereau, J. (1992) · Nature · doi:10.1038/360258a0 · Cited by 1,551 · see citing works

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.

Schwartz, R. H. (1992) · Cell · doi:10.1016/s0092-8674(05)80055-8 · Cited by 1,293 · see citing works

Induction of tolerance by IL-10-treated dendritic cells

Steinbrink, K., Wölfl, M., Jonuleit, H., Knop, J., & Enk, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4772 · Cited by 1,245 · see citing works

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.

Caux, C., Vanbervliet, B., Massacrier, C., Dezutter‐Dambuyant, C., de Saint-Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D., & Banchereau, J. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.695 · Cited by 920 · see citing works

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.

Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., & Storkus, W. J. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.1.87 · Cited by 828 · see citing works

Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily.

Zhou, L., & Tedder, T. F. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3821 · Cited by 751 · see citing works

Molecular Cloning of a Complementary DNA Encoding Human Macrophage-Specific Colony-Stimulating Factor (CSF-1)

Kawasaki, E. S., Ladner, M. B., Wang, A. M., Arsdell, J. V., Warren, M. K., Coyne, M. Y., Schweickart, V. L., Lee, M.-T., Wilson, K. J., Boosman, A., et al. (1985) · Science · doi:10.1126/science.2996129 · Cited by 522 · see citing works

CSF‐1—A mononuclear phagocyte lineage‐specific hemopoietic growth factor

Stanley, E. R., Guilbert, L. J., Tushinski, R. J., & Bartelmez, S. H. (1983) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240210206 · Cited by 516 · see citing works

Erratum: Errata

(1996) · Nature Medicine · doi:10.1038/nm1196-1267 · Cited by 431 · see citing works

Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow

Reid, C. D. L., Stackpoole, A., Meager, A., & Tikerpae, J. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.8.2681 · Cited by 424 · see citing works

Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma.

Blay, J., Négrier, S., Combaret, V., Attali, S., Goillot, E., Merrouche, Y., Mercatello, A., Ravault, A., Tourani, J. M., & Jf, M. (1992) · PubMed · Cited by 420 · see citing works

Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer.

Rosenberg, S. A., Lotze, M. T., Yang, J., Linehan, W. M., Seipp, C. A., Calabro, S., Karp, S. E., Sherry, R. M., Steinberg, S. M., & White, D. E. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.12.1863 · Cited by 372 · see citing works

The host—tumor immune conflict: from immunosuppression to resistance and destruction

Chouaı̈b, S., Asselin‐Paturel, C., Mami‐Chouaib, F., Caignard, A., & Blay, J. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01115-8 · Cited by 350 · see citing works

Differentiation of human dendritic cells from monocytes in vitro

Chapuis, F., Rosenzwajg, M., Yagello, M., Ekman, M., Biberfeld, P., & Gluckman, J. C. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270213 · Cited by 338 · see citing works

TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors

Strobl, H., Riedl, E., Scheinecker, C., Bello-Fernández, C., Pickl, W. F., Rappersberger, K., Majdic, O., & Knapp, W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1499 · Cited by 300 · see citing works

Interleukin‐10 differentially regulates B7‐1 (CD80) and B7‐2 (CD86) expression on human peripheral blood dendritic cells

Buelens, C., Willems, F., Delvaux, A., Piérard, G. E., Delville, J., Velu, T., & Goldman, M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250940 · Cited by 275 · see citing works

TRAIL/Apo-2-ligand-induced apoptosis in human T cells

Jeremias, I., Herr, I., Böhler, T., & Debatin, K. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01 · Cited by 265 · see citing works

Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor

Blay, J., Burdin, N., Rousset, F., Lenoir, G., Biron, P., Philip, T. O., Banchereau, J., & Favrot, M. (1993) · Blood · doi:10.1182/blood.v82.7.2169.2169 · Cited by 247 · see citing works

Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production

Macatonia, S. E., Doherty, T. M., Knight, S. C., & O’Garra, A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.9.3755 · Cited by 242 · see citing works

Interleukin‐10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin‐4 and granulocyte/ macrophage‐colony‐stimulating factor

Buelens, C., Verhasselt, V., Groote, D. D., Thielemans, K., Goldman, M., & Willems, F. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270326 · Cited by 237 · see citing works

Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate

Szabolcs, P., Avigan, D., Gezelter, S., Ciocon, D., Moore, M., Steinman, R. M., & Young, J. W. (1996) · Blood · doi:10.1182/blood.v87.11.4520.bloodjournal87114520 · Cited by 218 · see citing works

Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells

Caux, C., Massacrier, C., Vanbervliet, B., Barthélémy, C., Liu, Y.-J., & Banchereau, J. (1994) · International Immunology · doi:10.1093/intimm/6.8.1177 · Cited by 192 · see citing works

IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.

Beissert, S., Hosoi, J., Grabbe, S., Asahina, A., & Granstein, R. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1280 · Cited by 184 · see citing works

Antigen-presenting cell types

Knight, S. C., & Stagg, A. J. (1993) · Current Opinion in Immunology · doi:10.1016/0952-7915(93)90056-x · Cited by 181 · see citing works

Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines.

Schendel, D. J., Gänsbacher, B., Oberneder, R., Kriegmair, M., Hofstetter, A. G., Riethmüller, G., & Segurado, O. G. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.8.4209 · Cited by 157 · see citing works

Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression.

Mitra, R. S., Judge, T. A., Nestle, F. O., Turka, L. A., & Nickoloff, B. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.6.2668 · Cited by 156 · see citing works

Interleukin‐10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells

Péguet‐Navarro, J., Moulon, C., Caux, C., Dalbiez‐Gauthier, C., Banchereau, J., & Schmitt, D. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240416 · Cited by 144 · see citing works

A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma.

Brändle, D., Brasseur, F., Weynants, P., Boon, T., & den Eynde, B. J. V. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2501 · Cited by 143 · see citing works

Bone Marrow‐Derived Dendritic Cells Serve as Potent Adjuvants for Peptide‐Based Antitumor Vaccines

Mayordomo, J. I., Zorina, T. D., Storkus, W. J., Zitvogel, L., García-Prats, M. D., DeLeo, A. B., & Lotze, M. T. (1997) · Stem Cells · doi:10.1002/stem.150094 · Cited by 136 · see citing works

Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms

Émilie, D., Wijdenes, J., Gisselbrecht, C., Jarrousse, B., Billaud, É., Blay, J., Gabarre, J., Gaillard, J., Brochier, J., & Raphaël, M. (1994) · Blood · doi:10.1182/blood.v84.8.2472.2472 · Cited by 118 · see citing works

Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins

Aprikian, A. G., Tremblay, L., Han, K., & Chevalier, S. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970729)72:3 · Cited by 112 · see citing works

Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases.

Honda, M., KITAMURA, K., Mizutani, Y., Oishi, M., Arai, M., Okura, T., Igarahi, K., Yasukawa, K., Hirano, T., Kishimoto, T., et al. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4059 · Cited by 102 · see citing works

Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study.

Tartour, É., Blay, J., Dorval, T., Escudier, B. J., Mosseri, V., Douillard, J., Deneux, L., Gorin, I., Négrier, S., Mathiot, C., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1697 · Cited by 98 · see citing works

Interleukin-6 synergizes with M-CSF in the formation of macrophage colonies from purified human marrow progenitor cells

Bot, F., van Eijk, L. T., Broeders, L., Aarden, L. A., & Löwenberg, B. (1989) · Blood · doi:10.1182/blood.v73.2.435.435 · Cited by 91 · see citing works

Interleukin 6 is a permissive factor for monocytic colony formation by human hematopoietic progenitor cells.

Jansen, J. H., Kluin‐Nelemans, H. C., Damme, J. V., Wientjens, G. J. H. M., Willemze, R., & Fibbe, W. E. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.4.1151 · Cited by 75 · see citing works

Cellular immune response to human renal‐cell carcinomas: Definition of a common antigen recognized by HLA‐A2‐restricted cytotoxic T‐Lymphocyte (CTL) clones

Bernhard, H., Karbach, J., Wölfel, T., Busch, P., Störkel, S., Stöckle, M., Wölfel, C., Seliger, B., Huber, C., Büschenfelde, K. M. Z., et al. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590621 · Cited by 58 · see citing works

Granulocytic and monocytic differentiation of CD34hi cells is associated with distinct changes in the expression of the PU.1- regulated molecules, CD64 and macrophage colony-stimulating factor receptor

Olweus, J., Thompson, P., & Lund-Johansen, F. (1996) · Blood · doi:10.1182/blood.v88.10.3741.bloodjournal88103741 · Cited by 47 · see citing works

Interleukin-6 and TNFα production in human renal cell carcinoma

Gogusev, J., Augusti, M., Chrétien, Y., & Droz, D. (1993) · Kidney International · doi:10.1038/ki.1993.285 · Cited by 44 · see citing works

In Vitro Regulation of Dendritic Cell Development and Function

Caux, C., & Banchereau, J. (1996) · Blood cell biochemistry · doi:10.1007/978-0-585-31728-1_11 · Cited by 35 · see citing works

In vivo cytokine production and recombinant interleukin 2 immunotherapy: an insight into the possible mechanisms underlying clinical responses

Deehan, D., Heys, S. D., Simpson, W., Broom, J. I., Franks, C. R., & Eremin, O. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.222 · Cited by 24 · see citing works

Endogenously Produced Interleukin 6 is an Accessory Cytokine for Dendritic Cell Hematopoiesis

Santiago‐Schwarz, F., Tucci, J., & Carsons, S. E. (1996) · Stem Cells · doi:10.1002/stem.140225 · Cited by 22 · see citing works

Local Production of Interleukin 6 by Renal Adenocarcinoma In Vivo

Blay, J., Schemann, S., & Favrot, M. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.3.238 · Cited by 22 · see citing works

Comparison of Cytogenetics, Cytokine Secretion, and Oncogene Expression in Primary Cultures of Renal Carcinoma Cells

Lahn, M., Kunzmann, R., Köhler, G., Iklé, D. N., Hentrich, I., Jesuiter, H., Kulmburg, P., Veelken, H., Mackensen, A., Rosenthal, F. M., et al. (2009) · Oncology · doi:10.1159/000227730 · Cited by 14 · see citing works

Myeloid-derived-suppressor cells as regulators of the immune system

Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · see citing works

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · see citing works

Tumour-educated macrophages promote tumour progression and metastasis

Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,365 · see citing works

NF-κB: linking inflammation and immunity to cancer development and progression

Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,091 · see citing works

Immunosuppressive networks in the tumour environment and their therapeutic relevance

Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057 · see citing works

Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms

Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000 · see citing works

Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer

Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,340 · see citing works

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity

Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314 · see citing works

Colony-stimulating factors in inflammation and autoimmunity

Hamilton, J. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2356 · Cited by 1,305 · see citing works

Immunological hallmarks of stromal cells in the tumour microenvironment

Turley, S. J., Cremasco, V., & Astarita, J. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3902 · Cited by 1,140 · see citing works

Mechanisms and functional significance of tumour-induced dendritic-cell defects

Gabrilovich, D. I. (2004) · Nature reviews. Immunology · doi:10.1038/nri1498 · Cited by 1,022 · see citing works

IL-6 switches the differentiation of monocytes from dendritic cells to macrophages

Chomarat, P., Banchereau, J., Davoust, J. M., & Palucka, K. (2000) · Nature Immunology · doi:10.1038/82763 · Cited by 906 · see citing works

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

Cheng, P., Corzo, C. A., Luetteke, N., Yu, B., Nagaraj, S., Bui, M. M., Ortiz, M. L., Nacken, W. K. F., Sorg, C., Vogl, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080132 · Cited by 904 · see citing works

Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression

Serafini, P., Borrello, I., & Bronte, V. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.005 · Cited by 758 · see citing works

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome

Gobert, M., Treilleux, I., Bendriss-Vermare, N., Bachelot, T., Goddard-Leon, S., Arfi, V., Biota, C., Doffin, A. C., Durand, I., Olive, D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2360 · Cited by 758 · see citing works

Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells

Nauta, A. J., Kruisselbrink, A. B., Lurvink, E. G. A., Willemze, R., & Fibbe, W. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2080 · Cited by 741 · see citing works

Tumor-derived lactic acid modulates dendritic cell activation and antigen expression

Gottfried, E., Kunz-Schughart, L. A., Ebner, S., Mueller-Klieser, W., Hoves, S., Andreesen, R., Mackensen, A., & Kreutz, M. (2006) · Blood · doi:10.1182/blood-2005-05-1795 · Cited by 729 · see citing works

Clinical significance of defective dendritic cell differentiation in cancer.

Almand, B., Resser, J. R., Lindman, B. R., Nadaf, S., Clark, J. I., Kwon, E. D., Carbone, D. P., & Gabrilovich, D. I. (2000) · PubMed · Cited by 699 · see citing works

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

Zou, W., Machelon, V., L’Herminé, A. C., Borvak, J., Mercier‐Nomé, F., Isaeva, T., Wei, S., Krzysiek, R., Durand–Gasselin, I., Gordon, A. N., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1339 · Cited by 653 · see citing works

Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.

Bunt, S. K., Yang, L.-L., Sinha, P., Clements, V., Leips, J., & Ostrand-Rosenberg, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2354 · Cited by 680 · see citing works

Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy

Tang, T., Huang, X., Zhang, G., Hong, Z., Bai, X., & Liang, T. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00449-4 · Cited by 613 · see citing works

Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells

Marigo, I., Dolcetti, L., Serafini, P., Zanovello, P., & Bronte, V. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00602.x · Cited by 608 · see citing works

Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment

Fu, C., & Jiang, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03059 · Cited by 602 · see citing works

Deciphering and Reversing Tumor Immune Suppression

Motz, G. T., & Coukos, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.005 · Cited by 600 · see citing works

Collagen as a double-edged sword in tumor progression

Fang, M., Yuan, J., Peng, C., & Li, Y. (2014) · Tumor Biology · doi:10.1007/s13277-013-1511-7 · Cited by 580 · see citing works

CCL2 and Interleukin-6 Promote Survival of Human CD11b+ Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization

Roca, H., Varsos, Z. S., Sud, S., Craig, M. J., Chi, Y., & Pienta, K. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042671 · Cited by 567 · see citing works

In Breast Carcinoma Tissue, Immature Dendritic Cells Reside within the Tumor, Whereas Mature Dendritic Cells Are Located in Peritumoral Areas

Bell, D., Chomarat, P., Broyles, D., Netto, G., Harb, G. M., Lebecque, S., Valladeau, J., Davoust, J., Palucka, K. A., & Banchereau, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1417 · Cited by 544 · see citing works

Defining GM-CSF– and Macrophage-CSF–Dependent Macrophage Responses by In Vitro Models

Lacey, D. C., Achuthan, A. A., Fleetwood, A. J., Dinh, H., Roiniotis, J., Scholz, G. M., Chang, M. W., Beckman, S. K., Cook, A. D., & Hamilton, J. A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103426 · Cited by 529 · see citing works

Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells

Obermajer, N., Muthuswamy, R., Lesnock, J. L., Edwards, R. P., & Kaliński, P. (2011) · Blood · doi:10.1182/blood-2011-07-365825 · Cited by 499 · see citing works

Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells

Duluc, D., Delneste, Y., Tan, F., Moles, M., Grimaud, L., Lenoir, J., Preisser, L., Anegón, I., Catala, L., Ifrah, N., et al. (2007) · Blood · doi:10.1182/blood-2007-02-072587 · Cited by 490 · see citing works

PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment

Obermajer, N., Muthuswamy, R., Odunsi, K. O., Edwards, R. P., & Kaliński, P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2449 · Cited by 465 · see citing works

Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer

Nefedova, Y., Huang, M., Kusmartsev, S., Bhattacharya, R., Cheng, P., Salup, R., Jove, R., & Gabrilovich, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.464 · Cited by 464 · see citing works

Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.

Gabrilovich, D. I., Ishida, T., Nadaf, S., Ohm, J. E., & Carbone, D. P. (1999) · PubMed · Cited by 459 · see citing works

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6

Ratta, M., Fagnoni, F. F., Curti, A., Vescovini, R., Sansoni, P., Oliviero, B., Fogli, M., Ferri, E., della Cuna, G. R., Tura, S., et al. (2002) · Blood · doi:10.1182/blood.v100.1.230 · Cited by 442 · see citing works

Circulating interleukin‐6 predicts survival in patients with metastatic breast cancer

Salgado, R., Junius, S., Benoy, I. H., van Dam, P. A., Vermeulen, P., Marck, E. V., Huget, P., & Dirix, L. Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10833 · Cited by 435 · see citing works

Tertiary lymphoid structures, drivers of the anti‐tumor responses in human cancers

Dieu‐Nosjean, M., Giraldo, N. A., Kaplon, H., Germain, C., Fridman, W. H., & Sautès‐Fridman, C. (2016) · Immunological Reviews · doi:10.1111/imr.12405 · Cited by 417 · see citing works

Macrophage Inflammatory Protein 3α Is Expressed at Inflamed Epithelial Surfaces and Is the Most Potent Chemokine Known in Attracting Langerhans Cell Precursors

Dieu‐Nosjean, M., Massacrier, C., Homey, B., Vanbervliet, B., Pin, J., Vicari, A. P., Lebecque, S., Dezutter‐Dambuyant, C., Schmitt, D., Zlotnik, A., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.705 · Cited by 378 · see citing works

Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin

Remark, R., Alifano, M., Cremer, I., Mansuet‐Lupo, A., Dieu‐Nosjean, M., Riquet, M., Crozet, L., Ouakrim, H., Goc, J., Cazes, A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3847 · Cited by 391 · see citing works

Transcriptional regulation of myeloid-derived suppressor cells

Condamine, T., Mastio, J., & Gabrilovich, D. I. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4ri0515-204r · Cited by 368 · see citing works

M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells

Heusinkveld, M., van Steenwijk, P. J. D. V., Goedemans, R., Ramwadhdoebé, T. H., Gorter, A., Welters, M. J. P., van Hall, T., & van der Burg, S. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100889 · Cited by 368 · see citing works

Tumor-Associated Macrophages in Breast Cancer

Leek, R., & Harris, A. L. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1020304003704 · Cited by 353 · see citing works

Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators

Ben‐Baruch, A. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.006 · Cited by 336 · see citing works

Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.

Hartmann, E., Wollenberg, B., Rothenfußer, S., Wagner, M., Wellisch, D., Mack, B., Giese, T., Gires, O., Endres, S., & Hartmann, G. (2003) · PubMed · Cited by 335 · see citing works

Dendritic cell dysfunction in cancer: A mechanism for immunosuppression

Pinzón‐Charry, A., Maxwell, T., & López, J. A. (2005) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2005.01371.x · Cited by 328 · see citing works

PD‐L1 expression on tolerogenic APCs is controlled by STAT‐3

Wölfle, S. J., Strebovsky, J., Bartz, H., Sähr, A., Arnold, C., Kaiser, C., Dalpke, A. H., & Heeg, K. M. (2010) · European Journal of Immunology · doi:10.1002/eji.201040979 · Cited by 325 · see citing works

Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function

Pan, P., Wang, G. X., Yin, B., Ozao, J. J., Ku, H. T., Divino, C. M., & Chen, S. (2007) · Blood · doi:10.1182/blood-2007-04-086835 · Cited by 319 · see citing works

Regulation of Dendritic Cell Differentiation and Antitumor Immune Response in Cancer by Pharmacologic-Selective Inhibition of the Janus-Activated Kinase 2/Signal Transducers and Activators of Transcription 3 Pathway

Nefedova, Y., Nagaraj, S., Rosenbauer, A., Muro‐Cacho, C., Sebti, S. M., & Gabrilovich, D. I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0529 · Cited by 318 · see citing works

Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients

Bachelot, T., Ray-Coquard, I., Ménétrier‐Caux, C., Rastkha, M., Duc, A., & Blay, J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600956 · Cited by 317 · see citing works

Inflammatory cell infiltration of tumors: Jekyll or Hyde

Talmadge, J. E., Donkor, M. K., & Scholar, E. M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9072-0 · Cited by 311 · see citing works

Active immunization against cancer with dendritic cells: The near future

Steinman, R. M., & Dhodapkar, M. V. (2001) · International Journal of Cancer · doi:10.1002/ijc.1503 · Cited by 299 · see citing works

Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy

Keilholz, U., Weber, J. S., Finke, J. H., Gabrilovich, D. I., Kast, W. M., Disis, M. L., Kirkwood, J. M., Scheibenbogen, C., Schlom, J., Maino, V. C., et al. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200203000-00001 · Cited by 298 · see citing works

Immature myeloid cells and cancer-associated immune suppression

Kusmartsev, S. A., & Gabrilovich, D. I. (2002) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0280-8 · Cited by 297 · see citing works

Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species

Kusmartsev, S. A., & Gabrilovich, D. I. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0103010 · Cited by 292 · see citing works

The Macrophage Growth Factor CSF-1 in Mammary Gland Development and Tumor Progression

Lin, E. Y., Gouon–Evans, V., Nguyen, A., & Pollard, J. W. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1020399802795 · Cited by 292 · see citing works

Targeting STAT3 affects melanoma on multiple fronts

Kortylewski, M., Jove, R., & Yu, H. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-1580-1 · Cited by 282 · see citing works

Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

Schreibelt, G., Tel, J., Sliepen, K., Benítez‐Ribas, D., Figdor, C. G., Adema, G. J., & de Vries, I. J. M. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0833-1 · Cited by 270 · see citing works

Obesity and cancer: existing and new hypotheses for a causal connection

Stone, T. W., McPherson, M., & Gail Darlington, L. (2018) · eBioMedicine · doi:10.1016/j.ebiom.2018.02.022 · Cited by 262 · see citing works

Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy

Fong, L. H., Brockstedt, D. G., Benike, C. J., Breen, J. K., Strang, G., Ruegg, C. L., & Engleman, E. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.7150 · Cited by 252 · see citing works

Altered maturation of peripheral blood dendritic cells in patients with breast cancer

Bella, S. D., Gennaro, M., Vaccari, M., Ferraris, C., Nicola, S., Riva, A., Clerici, M., Greco, M., & Villa, M. L. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601243 · Cited by 239 · see citing works

Tumors Promote Altered Maturation and Early Apoptosis of Monocyte-Derived Dendritic Cells

Kiertscher, S. M., Luo, J., Dubinett, S. M., & Roth, M. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1269 · Cited by 238 · see citing works

Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.

Sharma, S. P., Stolina, M., Yang, S.-C., Baratelli, F. E., Lin, J. F.-H., Atianzar, K., Luo, J., Zhu, L., Lin, Y., Huang, M., et al. (2003) · PubMed · Cited by 234 · see citing works

Regulatory T Cells in Ovarian Cancer: Biology and Therapeutic Potential

Barnett, B. G., Kryczek, I., Cheng, P. J., Zou, W., & Curiel, T. J. (2005) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2005.00330.x · Cited by 233 · see citing works

On the origin of myeloid-derived suppressor cells

Millrud, C. R., Bergenfelz, C., & Leandersson, K. (2016) · Oncotarget · doi:10.18632/oncotarget.12278 · Cited by 232 · see citing works

Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment

Kopfstein, L., & Christofori, G. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5296-8 · Cited by 230 · see citing works

Tumour escape from immune surveillance through dendritic cell inactivation

Vicari, A. P., Caux, C., & Trinchieri, G. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0400 · Cited by 229 · see citing works

Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages

Wang, Q., Ni, H., Lan, L., Wei, X., Xiang, R., & Wang, Y. (2010) · Cell Research · doi:10.1038/cr.2010.52 · Cited by 219 · see citing works

Monocyte Selectivity and Tissue Localization Suggests a Role for Breast and Kidney–Expressed Chemokine (Brak) in Macrophage Development

Kurth, I., Willimann, K., Schaerli, P., Hunziker, T., Clark‐Lewis, I., & Moser, B. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.855 · Cited by 216 · see citing works

Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers

Becht, É., Giraldo, N. A., Germain, C., de Reyniès, A., Laurent‐Puig, P., Zucman‐Rossi, J., Dieu‐Nosjean, M., Sautès‐Fridman, C., & Fridman, W. H. (2016) · Advances in immunology · doi:10.1016/bs.ai.2015.12.002 · Cited by 213 · see citing works

Interferon-γ switches monocyte differentiation from dendritic cells to macrophages

Delneste, Y., Charbonnier, P., Herbault, N., Magistrelli, G., Caron, G., Bonnefoy, J., & Jeannin, P. (2002) · Blood · doi:10.1182/blood-2002-04-1164 · Cited by 211 · see citing works

Myeloid‐derived suppressor cells in cancer: recent progress and prospects

Khaled, Y. S., Ammori, B. J., & Elkord, E. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.29 · Cited by 208 · see citing works

Correlation Between Postoperative Infective Complications and Long-Term Outcomes After Hepatic Resection for Colorectal Liver Metastasis

Farid, S. G., Aldouri, A., Morris‐Stiff, G. J., Khan, A. Z., Toogood, G. J., Lodge, J. P. A., & Prasad, R. K. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181bfda3c · Cited by 209 · see citing works

Prostanoids Play a Major Role in the Primary Tumor-Induced Inhibition of Dendritic Cell Differentiation

Sombroek, C. C., Stam, A. G. M., Masterson, A. J., Lougheed, S. M., Schakel, M. J. A. G., Meijer, C. J. L. M., Pinedo, H. M., van den Eertwegh, A. J. M., Scheper, R. J., & de Gruijl, T. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4333 · Cited by 204 · see citing works

Gangliosides from Human Melanoma Tumors Impair Dendritic Cell Differentiation from Monocytes and Induce Their Apoptosis

Péguet‐Navarro, J., Sportouch, M., Popa, I., Berthier‐Vergnes, O., Schmitt, D., & Portoukalian, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3488 · Cited by 203 · see citing works

Kidney Single-Cell Atlas Reveals Myeloid Heterogeneity in Progression and Regression of Kidney Disease

Conway, B. R., O'Sullivan, E. D., Cairns, C., O’Sullivan, J., Simpson, D. J., Salzano, A., Connor, K. L., Ding, P., Humphries, D. C., Stewart, K., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020060806 · Cited by 199 · see citing works

Dendritic Cells Recognize Tumor-Specific Glycosylation of Carcinoembryonic Antigen on Colorectal Cancer Cells through Dendritic Cell–Specific Intercellular Adhesion Molecule-3–Grabbing Nonintegrin

van Gisbergen, K. P. J. M., Aarnoudse, C. A., Meijer, G. A., Geijtenbeek, T. B. H., & van Kooyk, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4140 · Cited by 192 · see citing works

Balance of MafB and PU. 1 specifies alternative macrophage or dendritic cell fate

Bakri, Y., Sarrazin, S., Mayer, U. P., Tillmanns, S., Nerlov, C., Boned, A., & Sieweke, M. H. (2005) · Blood · doi:10.1182/blood-2004-04-1448 · Cited by 187 · see citing works

The fibroblast: Sentinel cell and local immune modulator in tumor tissue

Silzle, T., Randolph, G. J., Kreutz, M. P., & Kunz‐Schughart, L. A. (2003) · International Journal of Cancer · doi:10.1002/ijc.11542 · Cited by 185 · see citing works

Induction of potent antitumor immunity by in situ targeting of intratumoral DCs

Furumoto, K., Soares, L. R. B., Engleman, E. G., & Mérad, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19762 · Cited by 206 · see citing works

Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer

Kusmartsev, S. A., & Gabrilovich, D. I. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9002-6 · Cited by 183 · see citing works

Induction of potent antitumor immunity by in situ targeting of intratumoral DCs

Furumoto, K., Soares, L., Engleman, E. G., & Merad, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419762 · Cited by 180 · see citing works

Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells

Yañez, R., Oviedo, A., Aldea, M., Bueren, J. A., & Lamana, M. L. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.08.008 · Cited by 177 · see citing works

Interleukin-6, Interleukin-10, and Vascular Endothelial Growth Factor in Metastatic Renal Cell Carcinoma: Prognostic Value of Interleukin-6—From the Groupe Français d'Immunothérapie

Négrier, S., Pérol, D., Ménétrier‐Caux, C., Escudier, B. J., Pallardy, M., Ravaud, A., Douillard, J., Chevreau, C., Lasset, C., & Blay, J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.121 · Cited by 176 · see citing works

Chemokines and Dendritic Cell Traffic

Sozzani, S., Allavena, P., Vecchi, A., & Mantovani, A. (2000) · Journal of Clinical Immunology · doi:10.1023/a:1006659211340 · Cited by 171 · see citing works

Reduced T-Cell and Dendritic Cell Function Is Related to Cyclooxygenase-2 Overexpression and Prostaglandin E2 Secretion in Patients With Breast Cancer

Pockaj, B. A., Basu, G. D., Pathangey, L. B., Gray, R. J., Hernández‐Davó, J. L., Gendler, S. J., & Mukherjee, P. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.05.027 · Cited by 168 · see citing works

Dendritic Cells and Tumor Microenvironment: A Dangerous Liaison

Fricke, I., & Gabrilovich, D. I. (2006) · Immunological Investigations · doi:10.1080/08820130600803429 · Cited by 165 · see citing works

Tumor-derived factors modulating dendritic cell function

Zong, J., Keskinov, A. A., Shurin, G. V., & Shurin, M. R. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1820-y · Cited by 165 · see citing works

Elimination of Metastatic Melanoma Using Gold Nanoshell-Enabled Photothermal Therapy and Adoptive T Cell Transfer

Bear, A. S., Kennedy, L. C., Young, J. K., Perna, S. K., Almeida, J. P. M., Lin, A. Y., Eckels, P. C., Drezek, R. A., & Foster, A. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069073 · Cited by 164 · see citing works

Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?

Shurin, M. R., Shurin, G. V., Lokshin, A. E., Yurkovetsky, Z. R., Gutkin, D. W., Chatta, G. S., Zhong, H., Han, B., & Ferris, R. L. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9010-6 · Cited by 162 · see citing works

Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and In vivo Growth of Human Oral Squamous Cell Carcinoma

Shinriki, S., Jono, H., Ota, K., Ueda, M., Kudo, M., Ota, T., Oike, Y., Endo, M., Ibusuki, M., Hiraki, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0287 · Cited by 163 · see citing works

Elevated Interleukin-6 and G-CSF in Human Pancreatic Cancer Cell Conditioned Medium Suppress Dendritic Cell Differentiation and Activation

Bharadwaj, U., Li, M., Zhang, R., Chen, C., & Yao, Q. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3963 · Cited by 160 · see citing works

Dendritic cells: Immunological sentinels with a central role in health and disease

Stockwin, L. H., McGonagle, D., Martin, I. G., & Blair, G. E. (2000) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2000.00888.x · Cited by 156 · see citing works

Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms

Vicari, A. P., Aït‐Yahia, S., Chemin, K., Müeller, A., Zlotnik, A., & Caux, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1992 · Cited by 153 · see citing works

Novel immunosuppressive properties of interleukin‐6 in dendritic cells: inhibition of NF‐κB binding activity and CCR7 expression

Hegde, S., Pahne, J., & Smola, S. (2004) · The FASEB Journal · doi:10.1096/fj.03-0969fje · Cited by 152 · see citing works

Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease

O’Connor, P. M. J., Lapointe, T. K., Beck, P. L., & Buret, A. G. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21217 · Cited by 151 · see citing works

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients

Manuel, M., Trédan, O., Bachelot, T., Clapisson, G., Courtier, A., Parmentier, G., Rabeony, T., Grivès, A., Perez, S., Mouret, J.-F., et al. (2012) · OncoImmunology · doi:10.4161/onci.19545 · Cited by 150 · see citing works

Dendritic Cell-Specific ICAM-3–Grabbing Nonintegrin Expression on M2-Polarized and Tumor-Associated Macrophages Is Macrophage-CSF Dependent and Enhanced by Tumor-Derived IL-6 and IL-10

Domínguez‐Soto, Á., Sierra‐Filardi, E., Puig‐Kröger, A., Pérez-Maceda, B. T., Gómez, F., Corcuera, M. T., Sánchez‐Mateos, P., & Corbí, A. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000475 · Cited by 147 · see citing works

The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response.

Orsini, E., Guarini, A. R., Chiaretti, S., Mauro, F. R., & Foà, R. (2003) · PubMed · Cited by 148 · see citing works

Monocyte-Derived CD1a+ and CD1a− Dendritic Cell Subsets Differ in Their Cytokine Production Profiles, Susceptibilities to Transfection, and Capacities to Direct Th Cell Differentiation

Chang, C.-C. J., Wright, A., & Punnonen, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3584 · Cited by 146 · see citing works

PGE2-Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells

Obermajer, N., Wong, J. L., Edwards, R. P., Odunsi, K. O., Moysich, K. B., & Kaliński, P. (2012) · Immunological Investigations · doi:10.3109/08820139.2012.695417 · Cited by 144 · see citing works

Pten Null Prostate Epithelium Promotes Localized Myeloid-Derived Suppressor Cell Expansion and Immune Suppression during Tumor Initiation and Progression

Garcia, A. J., Ruscetti, M. A., Arenzana, T. L., Tran, L. M., Bianchi-Frias, D., Sybert, E., Priceman, S. J., Wu, L., Nelson, P. S., Smale, S. T., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00090-14 · Cited by 143 · see citing works

IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells.

Ménétrier‐Caux, C., Thomachot, M. C., Alberti, L., Montmain, G., & Blay, J. (2001) · PubMed · Cited by 83 · see citing works

Immunosuppressive effect of renal cell carcinoma on phenotype and function of dendritic cells

Teng, L. L., Chen, Y., Ding, D., Dai, H., Liu, G., & Li, C. (2013) · International Urology and Nephrology · doi:10.1007/s11255-013-0595-8 · Cited by 25 · see citing works

Defining the molecular mechanisms that control the development of tumor dendritic cells. (66.32)

Tang, M., Diao, J., & Cattral, M. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.186.supp.66.32

Tumor-derived death receptor 6 modulates dendritic cell development

DeRosa, D. C., Ryan, P. J., Okragly, A. J., Witcher, D. R., & Benschop, R. J. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0413-1 · Cited by 29 · see citing works

Suppression of the Development and Function of Dendritic Cells by the Secretion of Tumor Cells

Li, C., Hou, C.-M., Wu, Y., Zhang, S., Zikuan, G., & Mao, N. (2002) · Europe PMC (PubMed Central)